Posted On: 10/15/2014 11:45:18 AM
Post# of 30035
The ONLY thing that will get us above .40 cents is a partnership with at least 30 million up front. I think we'll get something "concrete" on the LymPro partner, but I don't think it will be a blockbuster up front money deal. It will be more modest than that.
What is worrying me the most is that all Gerald would need to do is give us an update on how the "conversations" with AD pharmas were going, and it would stop the blood shed. But he isn't doing that. In the wake of Gerald's under delivering on expectations, shareholders are just waiting for some indication that AD Pharmas actually like the LP002 data and that they are waiting for Lympro to be ready for use.
Even without giving specific revenue guidance, if he gave us more of an indication of how the "soft selling" process is going.....that would help....if it has been positive.
What is worrying me the most is that all Gerald would need to do is give us an update on how the "conversations" with AD pharmas were going, and it would stop the blood shed. But he isn't doing that. In the wake of Gerald's under delivering on expectations, shareholders are just waiting for some indication that AD Pharmas actually like the LP002 data and that they are waiting for Lympro to be ready for use.
Even without giving specific revenue guidance, if he gave us more of an indication of how the "soft selling" process is going.....that would help....if it has been positive.
(0)
(0)Scroll down for more posts ▼
